A Single Acidic Residue Can Guide Binding Site Selection but Does Not Govern QacR Cationic-Drug Affinity
2011

QacR Binding Site Selection and Drug Affinity

publication Evidence: moderate

Author Information

Author(s): Kate M. Peters, Benjamin E. Brooks, Maria A. Schumacher, Ronald A. Skurray, Richard G. Brennan, Melissa H. Brown

Primary Institution: School of Biological Sciences, University of Sydney

Hypothesis

The acidic residues in the QacR multidrug-binding pocket guide cationic drug binding but do not significantly affect drug affinity.

Conclusion

The study concludes that the acidic residues in QacR primarily help position cationic drugs rather than significantly contributing to their binding affinity.

Supporting Evidence

  • Substitutions of acidic residues E90 and E120 had little impact on ligand affinity.
  • QacR mutants displayed similar maximal induction values to wild type QacR.
  • Drug binding was measured using fluorescence quenching and isothermal titration calorimetry.

Takeaway

This study found that certain parts of a protein help drugs find the best spot to attach, but they don't really change how strongly the drugs stick.

Methodology

The researchers substituted specific acidic residues in the QacR protein and analyzed their effects on drug binding and induction capabilities using structural and biochemical methods.

Limitations

The study primarily focuses on specific mutations and may not account for all possible interactions in the multidrug-binding pocket.

Digital Object Identifier (DOI)

10.1371/journal.pone.0015974

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication